AU5020700A - Treating allergic diseases with immunotherapy and ige antagonists - Google Patents

Treating allergic diseases with immunotherapy and ige antagonists

Info

Publication number
AU5020700A
AU5020700A AU50207/00A AU5020700A AU5020700A AU 5020700 A AU5020700 A AU 5020700A AU 50207/00 A AU50207/00 A AU 50207/00A AU 5020700 A AU5020700 A AU 5020700A AU 5020700 A AU5020700 A AU 5020700A
Authority
AU
Australia
Prior art keywords
immunotherapy
allergic diseases
treating allergic
ige antagonists
ige
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50207/00A
Inventor
Mark De Boer
Joost Van Neerven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanox Inc
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of AU5020700A publication Critical patent/AU5020700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU50207/00A 1999-05-26 2000-05-16 Treating allergic diseases with immunotherapy and ige antagonists Abandoned AU5020700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13606899P 1999-05-26 1999-05-26
US60136068 1999-05-26
PCT/US2000/013446 WO2000072879A1 (en) 1999-05-26 2000-05-16 TREATING ALLERGIC DISEASES WITH IMMUNOTHERAPY AND IgE ANTAGONISTS

Publications (1)

Publication Number Publication Date
AU5020700A true AU5020700A (en) 2000-12-18

Family

ID=22471131

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50207/00A Abandoned AU5020700A (en) 1999-05-26 2000-05-16 Treating allergic diseases with immunotherapy and ige antagonists

Country Status (2)

Country Link
AU (1) AU5020700A (en)
WO (1) WO2000072879A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045777A1 (en) 1998-03-10 1999-09-16 The Children's Hospital Of Philadelphia Compositions and methods for treatment of asthma
SE0101093D0 (en) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for the treatment of allergy and asthma
EP2477657A4 (en) * 2009-09-17 2012-09-26 Childrens Medical Center Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders
CN103289962B (en) * 2012-12-07 2015-03-18 天津三箭生物技术有限公司 Mouse anti-human CD23 monoclonal antibody and hybridoma cell strain secreting monoclonal antibody
GB201610198D0 (en) * 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
JP3156237B2 (en) * 1991-12-24 2001-04-16 雪印乳業株式会社 Anti-human IgE monoclonal antibody

Also Published As

Publication number Publication date
WO2000072879A1 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU2003286657A1 (en) Filters and methods of making and using the same
AU7339800A (en) Ophthalmic device and method of manufacture and use
AU5826100A (en) Benzazepinones and quinazolines
AU2003216591A1 (en) Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
WO2003083062A8 (en) Anti-il-tif antibodies and methods of using in inflammation
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU2002359512A1 (en) Belts and methods of use thereof
AUPQ155799A0 (en) Therapeutic methods and uses
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
AU4848200A (en) Intravascular device and methods of manufacture and use
AU2003215257A1 (en) Modified defensins and their use
AU2841801A (en) Triazolotriazinones and the use thereof
AU5020700A (en) Treating allergic diseases with immunotherapy and ige antagonists
AU2002341215A1 (en) Growth hormone variations in humans and their uses
AU2003297612A1 (en) 2-substituted-3-propenamide derivatives and methods of using the same
IL126113A0 (en) Methods for treatment of allergic diseases with ige
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003276844A1 (en) Formulations of modified antibodies and methods of making the same
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
AU2003244132A1 (en) Method of examining allergic disaese and drug for treating the same
AU2003244455A1 (en) Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
AU2003284597A1 (en) Apoptosis-associated protein and use thereof
AU2136401A (en) P450rai-2 and related proteins
AU2669201A (en) Taccalonolides and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase